the aid library

Malaria amongst children under five in sub-Saharan Africa: a scoping review of prevalence, risk factors and preventive interventions

Sarfo, J.O.; M. Amoadu, P.Y. Kordorwu, et al. (2023) CC2

Eur J Med Res 28, 80 (2023). https://doi.org/10.1186/s40001-023-01046-1. Africa has a higher burden of malaria-related cases and deaths globally. Children under five accounted for over two-thirds of all malaria deaths in sub-Saharan Africa (SSA). This scoping review aims to map evidence of the preva... more

Download (156)

View PDF (134)

Buruli ulcer in Africa: Geographical distribution, ecology, risk factors, diagnosis, and indigenous plant treatment options - A comprehensive review

Osei-Owusu J.; Fordjour Aidoo O.; Eshu F. et al. Heliyon (2023) C2

Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been documented in many South American, Asian, and Western Pacific countries and is widespread throughout much of Africa, especially in West... more

Download (350)

View PDF (405)

Parkinson’s Disease in Sub-Saharan Africa: A Review of Epidemiology, Genetics and Access to Care

U. Williams; O. Bandmann; R. Walker Journal of Movements Disorders (2018) C2

J Mov Disord > Volume 11(2); 2018 > Article Review Article J Mov Disord 2018; 11(2): 53-64. Published online: May 30, 2018 DOI: https://doi.org/10.14802/jmd.17028

Download (9401)

View PDF (1616)

Attitudes Towards Persons With Disability In Ghana

J. Slikker VSO Ghana (2009) C1

External Link

Buruli ulcer: wound care and rehabilitation

Frimpong, M.; F. S.Sarfo, M. Sarpong Duah, et al. Dove Medical Press Limited (2016) C1

Buruli ulcer caused by Mycobacterium ulcerans is a neglected tropical disease characterized by extensive ulceration involving predominantly the upper and lower limbs of patients. The disease is common in rural tropical communities in West and Central Africa, where access to proper health care is lim... more

External Link

Current Developments in Malaria Vaccination: A Concise Review on Implementation, Challenges, and Future Directions

Sallam, M.; A.O.Al-Kathib, K.S.Al-Mazhoum, et al. Dove Press (2025) CC

Clinical Pharmacology: Advances and Applications, 2025:17 29–47

Download (322)

View PDF (327)

Cognitive Training for Schizophrenia in Developing Countries: A Pilot Trial in Brazil (Clinical Study)

Pontes LM, Martins CB, Napolitano IC, Fonseca JR, Oliveira GM, Iso SM, Menezes AK, Vizzotto AD, di Sarno ES, Elkis H. Schizophrenia Research and Treatment (2013) CC

Cognitive deficits in schizophrenia can massively impact functionality and quality of life, furthering the importance of cognitive training. Despite the development of the field in Europe and in the United States, no programmes have been developed and tested in developing countries. Different cultur... more

Download (148)

View PDF (128)

BuDb: A Curated Drug Discovery Database for Buruli Ulcer

Kwofie, S.K.; et al. (2022) CC

Journal of Computational Biophysics and ChemistryVol. 22, No. 01, pp. 31-41 (2023)

Download (175)

View PDF (298)

Global progress toward the elimination of active trachoma: an analysis of 38 countries

Renneker, K.K.; et al. (2022) CC

Lancet Glob Health 2022; 10: e491–500

External Link

Assessment of prison life of persons with disability in Ghana

Joslin Dogbe, Ellis Owusu-Dabo, Anthony Edusei et al. (2016) CC

BioMed Central; BMC International Health and Human Rights (2016) 16:20; DOI 10.1186/s12914-016-0094-y

Download (144)

View PDF (124)

Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?

Sebti, M.; et al. (2024) CC

Pharmaceuticals 2024, 17(6), 691; https://doi.org/10.3390/ph17060691

External Link

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward

Minja, N.W.; Nakagaayi, D.; Aliku, T. et al. Frontiers in Cardiovascular Medicine (2022) CC

In 2015, the United Nations set important targets to reduce premature cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD burden and has one of the highest risks of dying from non-communicable diseases (NCDs) worldwide. There is currently an epide...miological transition on the continent, where NCDs is projected to outpace communicable diseases within the current decade. Unchecked increases in CVD risk factors have contributed to the growing burden of three major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age standardized disability-adjusted life years (DALYs) due to hypertensive heart disease (HHD) were recorded in Africa. The contributory causes of heart failure are changing—whilst HHD and cardiomyopathies still dominate, ischemic heart disease is rapidly becoming a significant contributor, whilst rheumatic heart disease (RHD) has shown a gradual decline. In a continent where health systems are traditionally geared toward addressing communicable diseases, several gaps exist to adequately meet the growing demand imposed by CVDs. Among these, high-quality research to inform interventions, underfunded health systems with high out-of-pocket costs, limited accessibility and affordability of essential medicines, CVD preventive services, and skill shortages. Overall, the African continent progress toward a third reduction in premature mortality come 2030 is lagging behind. More can be done in the arena of effective policy implementation for risk factor reduction and CVD prevention, increasing health financing and focusing on strengthening primary health care services for prevention and treatment of CVDs, whilst ensuring availability and affordability of quality medicines. Further, investing in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on interventions. This review summarizes the current CVD burden, important gaps in cardiovascular medicine in Africa, and further highlights priority areas where efforts could be intensified in the next decade with potential to improve the current rate of progress toward achieving a 33% reduction in CVD mortality. more

Download (729)

View PDF (622)

Plan de gestion de la sécurité sanitaire de l’eau: Guide pratique pour l’amélioration de la sécurité sanitaire de l’eau potable dans les petites communautés

Organisation mondiale de la Santé (OMS) (2017) C_WHO

Le présent guide pratique explique ce qu’est un plan de gestion de la sécurité sanitaire de l’eau (PGSSE) et de quelle manière celui-ci peut vous aider à renforcer la sécurité sanitaire de votre alimentation en eau potable, notamment par une amélioration progressive, étape par étape et... more

Download (211)

View PDF (512)

Guía de medicina tradicional para abordaje de la COVID-19

Ministerio de Salud, Bolivia (2021) C1

Serie: Documentos Técnico Normativiso 495

Download (385)

View PDF (351)

Dokumentation der 12. Fachtagung (Ver)störende Kinder Traumatisierte Kinder und Jugendliche als Herausforderung im pädagogischen Alltag

Netzwerk - Wiener Netzwerk gegen sexuelle Gewalt an Mädchen, Buben und Jugendlichen (2014) C1

Inhaltsangabe: Vorwort; Trauma bei Kindern und JugendlichenTraumatisierte Kinder im pädagogischen; Sekundäre Traumatisierung des Helfer_innensystems – Der Versuch zu verstehen und ein Pläydoyer für Enttabuisierung und Prävention; Trauma und Traumafolgen im Kindesalter; Zusammenarbeit mit E... more

Download (748)

View PDF (1003)

Nepal HIVision 2020. Ending the AIDS epidemic as a public health threat, by 2030. Nepali Version

Government of Nepal; Ministry of Health; National Centre for AIDS and STD Control (2016) C1

Download (146)

View PDF (155)

Traitement de l’infection à mycobacterium ulcerans (‎ulcère de Buruli)
recommended

Organisation Mondiale de la Santé OMS (2012) C_WHO

recommandations à l’intention des agents de santé

Download (144)

View PDF (113)

Rapid Extraction Method of Mycobacterium ulcerans DNA from Clinical Samples of Suspected Buruli Ulcer Patients

Frimpong, M.; H. Senanu Ahor; S.A. Sakyi, et al. (2019) CC

Diagnostics 2019, 9(4), 204; https://doi.org/10.3390/diagnostics9040204

Download (158)

View PDF (105)

Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection

Walsh, D.S.; F. Portaels, W.N. Meyers, et al. (2011) CC

Dermatologic Clinics Volume 29, Issue 1p1-8January 2011

Download (289)

View PDF (291)

Recent Advances in the Management Strategies for Buruli Ulcers

Popa G.; Muntean Al., Popa M. (2023) CC

Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.

Traitement de l’infection à mycobacterium ulcerans (‎ulcère de Buruli) recommended

Traitement de l’infection à mycobacterium ulcerans (‎ulcère de Buruli)
recommended